Biotechnology | Applied Legal Professional | National Defense| Strategist | Life Sciences Consultant | Government Contractor | KOL | Author

Founded in 2016

About

Monica Dudley-Weldon’s journey is one of resilience, advocacy, and unwavering determination in the face of adversity. What began as a mother’s fight to find answers for her son became a lifelong mission to drive change in rare disease, healthcare policy, biotechnology, and national security. Her story is rooted in love, strengthened by purpose, and defined by a relentless commitment to improving lives.

In November 2012, Monica’s life changed forever when her twin son, Beckett, became the first child diagnosed with the rare gene mutation SYNGAP1 at Texas Children’s Genetics Clinic. At only four months old, signs of developmental delay prompted Monica and her family to begin a difficult search for answers. Determined to help her son thrive, Monica began documenting Beckett’s journey through a blog, creating a trusted space for families, caregivers, and advocates facing similar challenges.

That grassroots effort quickly evolved into something much larger. In 2014, Monica founded the SYNGAP1 Foundation, the first organization of its kind dedicated to advancing research, raising awareness, and advocating for meaningful progress in SYNGAP1-related disorders. As founder and leader of the organization, Monica built programs, cultivated partnerships, and served as Primary Investigator on the SYNGAP1 Patient Registry and Natural History Study, helping shape the future of rare disease research and advocacy.

After a successful 23-year career teaching secondary science, Monica retired from education in 2016 to fully devote herself to the mission of advocacy, research, and systems change. She went on to found Monica Weldon Consulting, LLC, where she advises clients across biotechnology, national security, healthcare, policy, and innovation. Through her consulting work, Monica has become a recognized voice in rare disease business strategy, legislative engagement, and regulatory policy, working with lawmakers, pharmaceutical companies, patient groups, and healthcare stakeholders to influence meaningful outcomes.

Monica currently also serves as a Senior Advisor Consultant at Squire Patton Boggs LLP in Washington, DC. In this role, she brings strategic insight at the intersection of life sciences, government affairs, regulatory strategy, and national security-focused innovation.

Her expertise later expanded into national security and biotechnology manufacturing. Monica served as a Life Scientist through Leidos, supporting biotechnology manufacturing strategy, industrial base policy, supply chain resilience, and defense-related innovation aligned with Department of Defense priorities. Her work has included portfolio oversight, stakeholder coordination, and strategic support for large-scale biotechnology initiatives tied to national preparedness and long-term competitiveness.

Monica is also a prolific author, public speaker, and consultant whose scientific and policy contributions have earned national and international recognition. Her work has been published or featured in outlets including Nature Neuroscience, The Journal of Pediatrics, and Value in Health, and she has contributed to major policy and advocacy milestones, including the 21st Century Cures Act, the first ICD-10 code request for SYNGAP1-related disorders, and the inaugural SYNGAP1 Voices of the Patient and Caregiver Report.

She holds a bachelor’s degree in biology with a minor in psychology and secondary education from East Texas Baptist University, and a master’s degree in law focused on health regulation and policy from Northwestern University Pritzker School of Law. She is also a Virginia Governor appointee to the Commonwealth Health Research Board.

Above all, Monica is a proud mother of five children, including Beckett and Pyper, and grandmother to Ella and Dakota. Her advocacy has earned her numerous honors, including being named one of the Top 10 Most Influential Women Leaders of 2022. Whether in the boardroom, the policy arena, or the rare disease community, Monica continues to lead with courage, compassion, and conviction—leaving an indelible mark on healthcare, science, and society.

Awards & Recognitions

  • Monica Dudley-Weldon has been recognized as a 2024 honoree in the prestigious Marquis Who's Who directory. This honor highlights Monica's outstanding contributions to life sciences, health policy, or biomanufacturing], where she has consistently demonstrated excellence and leadership. With a career marked by innovation, strategic development, and a deep commitment to advancing the industry, Monica sets the standard in her field. This recognition is a testament to her unwavering dedication and impact on the global healthcare.

  • Monica Dudley-Weldon, Former President, CEO, and founder of SYNGAP1 Foundation, is a true professional in a challenging and competitive business. She has stood on the same podium as world-renowned corporate and key opinion leaders. As an advocate, she is considered the barometer for what an individual should strive to become.

  • Monica is recognized for her academic excellence as a 2021 inductee into the Honor Society at Northwestern University Pritzker School of Law. This prestigious honor was awarded for maintaining an outstanding A average while earning a Master of Science in Law degree. Monica's dedication to academic success reflects her commitment to mastering the complexities of law and its intersection with science, technology, and policy. This achievement underscores her passion for lifelong learning and excellence in legal education.

  • Monica Weldon was a proud nominee for the 9th Annual WEGO Health Awards in 2020. Recognized across multiple categories—Advocating for Another, Best in Show: Facebook, Healthcare Collaborator, Hilarious Patient Leader, and Patient Leader Hero—Monica's dedication to patient advocacy and healthcare collaboration shines through. These nominations celebrate Monica's impactful work in the health community, where she has consistently demonstrated compassion, leadership, and a unique ability to engage and inspire others.

  • In recognition of Rare Disease Day 2020, Global Shakers honored Monica Weldon as one of the Top 20 Rare Disease Key Opinion Leaders (KOLs). This prestigious acknowledgment celebrates Monica's unwavering commitment to raising awareness for some of the world's rarest diseases. As a dedicated patient advocate, Monica continues to make a profound impact in the rare disease community, championing the needs of patients and families through education, advocacy, and collaborative efforts. Her inclusion in this list underscores her leadership and influence in the global healthcare landscape.

  • We are proud to announce that Monica Weldon was a nominee for the 8th Annual WEGO Health Awards in 2019, recognized in the categories of Hilarious Patient Leader and Patient Leader Hero. These nominations celebrate Monica's unique ability to combine humor with heartfelt advocacy, making her a standout figure in the patient community. As a Patient Leader Hero, Monica's dedication to empowering others and driving positive change in healthcare is evident. Her work continues to inspire and uplift, leaving a lasting impact on those she serves.

  • Monica Weldon was honored as a nominee for the 7th Annual WEGO Health Awards in 2020, recognized in three categories: Hilarious Patient Leader, Patient Leader Hero, and Best in Blog. These nominations reflect Monica's exceptional ability to engage and uplift the patient community through humor, heartfelt advocacy, and impactful storytelling. As a Patient Leader Hero, Monica's work not only educates but also inspires, while her blog has become a trusted resource for those navigating the challenges of healthcare. Monica's dedication continues to make a significant difference in the lives of many.Item description

  • Global Genes™ would like to congratulate the following 2016 RARE Champion of Hope Nominees. These individuals and organizations have been recognized by their peers because of their extraordinary efforts in Advocacy, Science, Medical Care and Treatment, and Collaborations in Science.

  • Monica Weldon was selected as a DIA 2016 Patient Scholar, an honor that recognizes her commitment to advancing patient advocacy within the healthcare industry. As a Patient Scholar, Monica had the opportunity to collaborate with leading professionals, sharing her unique insights and experiences to help shape the future of healthcare. This recognition underscores Monica's dedication to empowering patients and ensuring their voices are heard in critical discussions about healthcare innovation and policy.

  • Monica Weldon was honored with a nomination for the 4th Annual WEGO Health Awards in 2015 in the category of Best in Blog. This recognition highlights Monica's talent for creating compelling and informative blog content that resonates deeply with readers. Her blog serves as a powerful platform for patient advocacy, offering insights, support, and inspiration to those navigating the complexities of healthcare. Monica's dedication to sharing her journey and knowledge has made her a trusted voice in the community.

  • Global Genes™ would like to congratulate the following 2015 RARE Champion of Hope Nominees. These individuals and organizations have been recognized by their peers because of their extraordinary efforts in Advocacy, Science, Medical Care and Treatment, and Collaborations in Science.

  • In 2003, Monica Weldon was nominated as an Educator Astronaut, a prestigious recognition that highlights her dedication to education and passion for space exploration. This nomination underscores Monica's commitment to inspiring future generations in STEM (Science, Technology, Engineering, and Mathematics) fields. As an Educator Astronaut nominee, Monica demonstrated the qualities of a leader and educator with the potential to bring the wonders of space into the classroom, fostering curiosity and a love for learning among students.